Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity. Data from the InChianti study

Atherosclerosis

Volumn 203, Issue 2, 2009, Pages 626-632

  Zuliani, Giovanni ^a   Volpato, Stefano ^a   Galvani, Matteo ^a   Blè, Alessandro ^f   Bandinelli, Stefania ^b   Corsi, Anna Maria ^c,d   Lauretani, Fulvio ^c   Maggio, Marcello ^e   Guralnik, Jack M ^f   Fellin, Renato ^a   Ferrucci, Luigi ^b,f  

^a Section of Internal Medicine   (Italy)

^b ASF Geriatric Rehabilitation   (Italy)

^c Geriatric Department   (Italy)

^d Degenerative and Neoplastic Diseases to Develop Novel Therapies   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

C reactive protein; Elderly; Metabolic syndrome; Systemic inflammation; Waist circumference

Indexed keywords

ANTIDIABETIC AGENT; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

AGE; AGED; ARTICLE; BODY MASS; COMMUNITY LIVING; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GERIATRIC PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; C-REACTIVE PROTEIN; COMORBIDITY; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; REGRESSION ANALYSIS;

EID: 62649130263     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.07.038     Document Type: Article

References (46)

1. Reaven G.M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416-422
3. Liese A.D., Mayer-Davis E.J., and Haffner S.M. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 20 (1998) 157-172
4. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., Lenfant C., American Heart Association, National Heart, Lung, and and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
5. Strandberg T.E., and Tilvis R.S. C reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20 (2000) 1057-1060
6. Ford E.S., Wayne H.G., and Dietz W.H. Prevalence of metabolic syndrome among U.S. adults: findings from the third national health and nutrition examination survey. JAMA 287 (2002) 356-359
7. Miccoli R., Bianchi C., Odoguardi L., et al. Prevalence of the metabolic syndrome among Italian adults according to the ATP III definition. Nutr Metab Cardiovasc Dis 15 (2005) 250-254
8. Pickup J.C., Mattock M.B., Chusney G.D., et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997) 1286-1292
9. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., et al. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
10. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
11. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
12. Strandberg T.E., and Tilvis R.S. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20 (2000) 1057-1060
13. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102 (2000) 42-47
14. Frohlich M., Imhof A., Berg G., et al. Association between C reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23 (2000) 1835-1839
15. Pickup J.C., and Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 41 (1998) 1241-1248
16. Tracy R.P. Inflammation in cardiovascular disease: cart, horse, or both?. Circulation 97 (1998) 2000-2002
17. Campos S.P., and Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 12 (1992) 1789-1797
18. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005) 939-949
19. Schrager M.A., Metter E.J., Simonsick E., et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102 (2007) 919-925
20. Bruunsgaard H., and Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 23 (2003) 15-39
21. Roubenoff R., Harris T.B., Abad L.W., Wilson P.W., Dallal G.E., and Dinarello C.A. Monocyte cytokine production in an elderly population: effect of age and inflammation. J Gerontol A Biol Sci Med Sci 53 (1998) M20-M26
22. Ferrucci L., Corsi A., Lauretani F., et al. The origins of age-related pro-inflammatory state. Blood 105 6 (2005) 2294-2299
23. Ferrucci L., et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 48 (2000) 1618-1625
24. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
25. Pearson T.A., Bazzarre T.L., Daniels S.R., et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 107 4 (2003) 645-651
26. Rittweger J., Beller G., Ehrig J., et al. Bone-muscle strength indices for the human lower leg. Bone 27 (2000) 319-326
27. Pisani P., Faggiano F., Krogh V., Palli D., Vineis P., and Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 26 (1997) 152-160
28. Bartali B., Turrini A., Salvini S., et al. Dietary intake estimated using different methods in two Italian older populations. Arch Gerontol Geriatr 38 (2004) 51-60
29. Newman A.B., Sutton-Tyrell K., and Kuller L.H. Lower-extremity arterial disease in older hypertensive adults. Arterioscler Thromb 13 (1993) 555-562
30. Santos A.C., Lopes C., Guimaraes J.T., and Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes 29 (2005) 1452-1456
31. Dupuy A.M., Jaussent I., Lacroux A., Durant R., Cristol J.P., and Delcourt C. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome. Gerontology 53 (2007) 329-339
32. Pouliot M.-C., Despres J.-P., Lemieux S., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73 (1994) 460-468
33. Seidell J.C., Oosterlee A., Deurenberg P., Hautavast J.G., and Ruijs J.H. Abdominal fat depots measured by computed tomography: effects of degree of obesity, sex, and age. Eur J Clin Nutr 42 (1988) 805-815
34. Despres J.-P., Prud'homme D., Pouliot M.C., Tremblay A., and Bouchard C. Estimation of deep abdominal adipose tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 54 (1991) 471-477
35. Ferland M., Despres J.-P., Tremblay A., et al. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 61 (1989) 139-148
36. Depres J.-P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
37. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
38. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and the risk of incident cardiovascular events: an 8-years follow-up of 14,719 initially healthy American women. Circulation 107 (2003) 391-397
39. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
40. Mohamed-Ali V., Goodrisk S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6 but not tumor necrosis factor-alpha, in vivo. J Clin Endocr Metab 82 (1997) 4196-4200
41. Lau D., Yan H., Abdel-Hafez M., and Kermouni A. Adipokines and the paracrine control of their production in obesity and diabetes. Int J Obes Relat Metab Disord 26 (2002) S111 (Abstract)
42. Beaufrere B., and Morio B. Fat and protein redistribution with aging: metabolic considerations. Eur J Clin Nutr 54 (2000) S48-53
43. Cree M.G., Newcomer B.R., Katsanos C.S., et al. Intramuscular and liver triglycerides are increased in the elderly. J Clin Endocrinol Metab 89 (2004) 3864-3871
44. Horber F.F., Ruber B., Thomi F.A., Jensen E.X., and Haeger P. Effect of sex and age on bone mass, body composition, and fuel metabolism in humans. Nutrition 13 (1997) 424-534
45. Zamboni M., Armellini F., Harris T., et al. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 66 (1997) 111-115
46. Morley J.E., and Baumgartner R.N. Cytokine-related aging process. J Geront Med Sci 59 9 (2004) M924-M929